Samsung Group, Quintiles Transnational Corp. Plan $266 Million Venture to Make Biologic Drugs

February 25, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Bloomberg -- Samsung Group, the South Korean company whose businesses range from electronics to ship-building, will partner with Quintiles Transnational Corp. to make biologic drugs as it seeks new businesses to drive growth.

Twitter
LinkedIn
Facebook
Email
Print

Alliances